Pharma Journalist - Page 730 of 923 -

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

FDA Approves Genentech’s Rituxan (rituximab) For Pemphigus Vulgaris

GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs

Vetter Strikes out on New Pathways to Further Develop the Injection Process

Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement

Celltrion Launches Bio CDMO Business for the Development of New Drugs

Biogen Enters Exclusive Option Agreement to Acquire TMS’ Phase 2 Asset for Acute Stroke

FDA and EMA Accept Regulatory Submissions for Review of Talazoparib

Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox

Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease

BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist